About Takara Bio Inc. (TKBIF) — Dividend Analysis 2026
Takara Bio Inc., together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names. It also provides contract services for regenerative medicine products, such as manufacturing of viral vectors and gene-transduced cells, quality and safety testing, and cell banking; and contract services for gene analysis and testing, including sequencing, intestinal flora analysis, comprehensive analysis of cancer-associated genes, and cell line creation through genome editing. In addition, the company is involved in developing platform technology for biologics development in areas, such as gene therapy. The company was incorporated in 2002 and is based in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.
Is TKBIF a good dividend investment in 2026?
TKBIF offers a 1.58% forward yield with a 50% payout ratio. Strand Safety Score: N/A. The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
TKBIF DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your TKBIF portfolio grows to $11.7K vs $11.6K without reinvestment. This is the compound interest effect in action.
TKBIF dividend growth history & forecast
TKBIF has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 1.58%.
ETFs do not file income statements or cash flow statements. Their dividend safety depends on the underlying index quality, fund methodology, and holdings composition. Use the Holdings page to analyze individual stocks in this fund.
🌍 TKBIF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold TKBIF.
Gross yield
1.58%
Tax rate
15.00%
After-tax yield
1.34%
Real yield (−CPI)
-1.46%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
1.58%
-1.22%
$158 / yr
🇺🇸 US Taxable (15%) ✓
15%
1.34%
-1.46%
$134 / yr
🇺🇸 US Taxable (20%)
20%
1.26%
-1.54%
$126 / yr
🇬🇧 UK ISA
0%
1.58%
-1.22%
$158 / yr
🇬🇧 UK Taxable
8.75%
1.44%
-1.36%
$144 / yr
🇨🇦 TFSA
0%
1.58%
-1.22%
$158 / yr
🇨🇦 CA Taxable
25%
1.19%
-1.61%
$119 / yr
🇦🇺 Super (pension)
15%
1.34%
-1.46%
$134 / yr
🇦🇺 AU Taxable
30%
1.11%
-1.69%
$111 / yr
🇩🇪 DE Taxable
26.375%
1.16%
-1.64%
$116 / yr
🇫🇷 FR Taxable
30%
1.11%
-1.69%
$111 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 TKBIF Income Goal & Break-Even
Dividend Break-Even
50yr+
Years for dividends to fully repay your TKBIF investment of $7.30/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$1.4K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$-1048.30
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in TKBIF for:
Shares needed
245,311
Capital required
$1,790,770
Monthly income
$2,000
Based on current dividend of $0.12/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 TKBIF Dividend Payment Schedule
TKBIF pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$0.24 / payment
$0.98 / year after tax
100 shares
$2.45 / payment
$9.78 / year after tax
1,000 shares
$24.46 / payment
$97.83 / year after tax
📊 TKBIF vs Healthcare Benchmarks
How TKBIF compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▼-1.22% vs sectorBelow avg
TKBIF
1.58%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
TKBIF
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
TKBIF
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TKBIF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ TKBIF Insider Activity
No recent SEC filings reported in the last 90 days.
📅
Next Earnings Report: 2026-05-11(in 40 days)
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TKBIF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →